Skip to main content
. 2022 Oct 11;11(20):5997. doi: 10.3390/jcm11205997
Conclusion—Recommendation: LMWH has the largest body of evidence regarding the beneficial role of thromboprophylaxis in hospitalized patients with COVID-19 and should be currently regarded as the drug of choice.